Agios Pharmaceuticals | AGIO - Trade Creditors



Agios Pharmaceuticals reported $17.53M in Trade Creditors for its fiscal quarter ending in June of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Agios Pharmaceuticals USD 17.53M 3.81M Jun/2025
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amgen USD 18.03B 15.63B Jun/2025
Arrowhead Research USD 33.05M 23.07M Jun/2025
Astellas Pharma JPY 165.89B 21.95B Jun/2025
AstraZeneca 23.99B 1.44B Jun/2025
Bayer EUR 6.04B 549M Jun/2025
Biogen USD 408.4M 16.9M Jun/2025
BioMarin Pharmaceutical 684.25M 390.5M Jun/2025
Bristol-Myers Squibb USD 5.43B 1.42B Jun/2025
Daiichi Sankyo JPY 518.54B 61.41B Jun/2025
Eli Lilly USD 4.08B 633.7M Jun/2025
Exelixis USD 25.82M 17.02M Jul/2025
Gilead Sciences USD 582M 155M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Incyte USD 1.41B 1.21B Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Merck USD 4.04B 261M Jun/2025
Moderna USD 175M 51M Jun/2025
Novartis USD 4.51B 245M Jun/2025
Novartis USD 4.51B 66M Jun/2025
Pfizer USD 5.17B 74M Jun/2025
Regeneron Pharmaceuticals USD 723.9M 18.4M Jun/2025
Roche Holding 4.35B 828M Dec/2024
Sarepta Therapeutics USD 136.7M 19.4M Jun/2025
Vertex Pharmaceuticals USD 3.71B 3.27B Jun/2025